Roar Biomedical

Roar Biomedical is a long-established, privately-held company operating as a specialized reagent and assay provider for the life sciences industry. Founded in 1997 and based in New York City, its core business revolves around proprietary fluorescence-based methods to measure protein activity, with a particular expertise in lipid transfer assays. The company generates revenue through product sales, licensing agreements, and co-branding partnerships, notably with MilliporeSigma, and its assays are utilized to support human clinical trials. It operates as a niche player with deep scientific validation but a limited public profile and product scope.

Proprietary fluorescence-based activity assays for measuring lipid metabolism enzyme function (e.g., CETP, LCAT).

Roar competes in the niche market of specialized biochemical activity assays. Competitors include other boutique assay developers and larger reagent companies (e.g., Cayman Chemical, Abcam) that offer similar products. Its competitive edge is deep specialization, strong IP, and direct validation in clinical trials.